Skip to content

Opening book details…

About this Medicine article

Management of common adverse events related to first-line dacomitinib use in EGFR mutation-positive non-small-cell lung cancer: a pooled safety analysis by Zhou, Qing; Wu, Yi-Long; Corral, Jesus; Nakagawa, Kazuhiko; Garon, Edward B; Sbar, Eric I; Wang, Tao; Sandin, Rickard; Noonan, Kay; Gernhardt, Diana; Mok, Tony S is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Zhou, Qing; Wu, Yi-Long; Corral, Jesus; Nakagawa, Kazuhiko; Garon, Edward B; Sbar, Eric I; Wang, Tao; Sandin, Rickard; Noonan, Kay; Gernhardt, Diana; Mok, Tony S
Publisher
Future Medicine; Future Medicine Ltd.; Informa Healthcare; Future Medicine Ltd (ISSN 1479-6694)
Published
2019
Field
Medicine (Health Sciences)

More by Zhou, Qing; Wu, Yi-Long; Corral, Jesus; Nakagawa, Kazuhiko; Garon, Edward B; Sbar, Eric I; Wang, Tao; Sandin, Rickard; Noonan, Kay; Gernhardt, Diana; Mok, Tony S

Browse all works by Zhou, Qing; Wu, Yi-Long; Corral, Jesus; Nakagawa, Kazuhiko; Garon, Edward B; Sbar, Eric I; Wang, Tao; Sandin, Rickard; Noonan, Kay; Gernhardt, Diana; Mok, Tony S